Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.

Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The goal of this study was to investigate the effect of natalizumab (NTZ) treatment on DC numbers, phenotype, and function in patients with multiple sclerosis (MS).Frequency and phenotype of myeloid and p...

Full description

Bibliographic Details
Main Authors: Pia Kivisäkk, Katiana Francois, Julvet Mbianda, Roopali Gandhi, Howard L Weiner, Samia J Khoury
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4116240?pdf=render